经皮穿刺活检前预测亚实性肺结节:人工神经网络与活检结果的比较
单中心回顾性研究纳入2013至2021年1459个亚实性结节,以CT后手术患者数据建立人工神经网络(ANN)模型,以活检后手术患者数据验证,比较ANN预测与经皮核心针活检(PCNB)病理诊断。结果显示SFB组ANN与PCNB准确率无显著差异(p=0.086),PCNB敏感度低于ANN(p=0.000)但特异度更高(p=0.001),PCNB诊断能力略优于ANN。
要点
- SFB组中ANN与PCNB诊断准确率无显著差异(p=0.086),PCNB诊断能力略高于ANN。
- PCNB敏感度低于ANN(p=0.000),特异度高于ANN(p=0.001)。
- 恶性肿瘤史、大小2-3 cm、体积>400 cm3及平均CT值≥-450 HU是选择PCNB的重要因素。
核心结论
- ANN与PCNB诊断SSNs准确率相当,但PCNB诊断能力略高于ANN;选择合适的患者进行PCNB对最大化SSN患者获益很重要。
研究设计与样本
- 单中心回顾性研究,使用2013至2021年间1459个SSNs数据;ANN以CT后手术(SFC)患者数据开发,以活检后手术(SFB)患者数据验证;将PCNB组ANN预测结果及活检后组织病理结果与该组手术后肺结节组织病理结果进行比较。
诊断标准与关键数值
- SFB组ANN与PCNB准确率无显著差异(p=0.086)。
- PCNB敏感度低于ANN(p=0.000),特异度高于ANN(p=0.001)。
- SFB组前驱病变及非肿瘤性病变发生率低于SFC组(p=0.000)。
- 恶性肿瘤史、大小2-3 cm、体积>400 cm3、平均CT值≥-450 HU是选择PCNB的重要因素。
临床应用与阅片要点
- 原文结论认为选择合适的患者进行PCNB对最大化SSN患者获益很重要,未给出具体选择流程或推荐等级。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To establish an artificial neural network (ANN) model to predict subsolid nodules (SSNs) before percutaneous core-needle biopsy (PCNB). The results of the two methods were compared to provide guidance on the treatment of SSNs.
MATERIALS AND METHODS: This was a single-centre retrospective study using data from 1,459 SSNs between 2013 and 2021. The ANN was developed using data from patients who underwent surgery following computed tomography (CT) (SFC) and validated using data from patients who underwent surgery following biopsy (SFB). The prediction results of the ANN for the PCNB group and the histopathological results obtained after biopsy were compared with the histopathological results of lung nodules in the same group after surgery. Additionally, the choice of predictors for PCNB was analysed using multivariate analysis.
RESULTS: There was no significant difference between the accuracies of the ANN and PCNB in the SFB group (p=0.086). The sensitivity of PCNB was lower than that of the ANN (p=0.000), but the specificity was higher (p=0.001). PCNB had better diagnostic ability than the ANN. The incidence of precursor lesions and non-neoplastic lesions in the SFB group was lower than that in the SFC group (p=0.000). A history of malignant tumours, size (2-3 cm), volume (>400 cm3) and mean CT value (≥-450 HU) are important factors for selecting PCNB.
CONCLUSIONS: Both ANN and PCNB have comparable accuracy in diagnosing SSNs; however, PCNB has a slightly higher diagnostic ability than ANN. Selecting appropriate patients for PCNB is important for maximising the benefit to SSN patients.
引用
- Chuang H, Yun L, Jiang-Ping L, et al. Predicting subsolid pulmonary nodules before percutaneous needle biopsy: a comparison of artificial neural network and biopsy results. Clin Radiol. 2023. PMID: 38160104. doi:10.1016/j.crad.2023.12.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。